C WorldWide Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.1M | Hold |
65,000
| – | – | 0.61% | 27 |
|
|
2026
Q1 | $19M | Hold |
65,000
| – | – | 0.41% | 32 |
|
|
2025
Q4 | $22.8M | Sell |
65,000
-23,000
| -26% | -$7.77M | 0.4% | 35 |
|
|
2025
Q3 | $28.4M | Sell |
88,000
-3,054
| -3% | -$950K | 0.44% | 27 |
|
|
2025
Q2 | $35.4M | Buy |
91,054
+1,615
| +2% | +$650K | 0.48% | 26 |
|
|
2025
Q1 | $38.9M | Sell |
89,439
-1,944
| -2% | -$780K | 0.48% | 24 |
|
|
2024
Q4 | $33.7M | Buy |
91,383
+21,239
| +30% | +$8.89M | 0.41% | 25 |
|
|
2024
Q3 | $36.5M | Hold |
70,144
| – | – | 0.38% | 43 |
|
|
2024
Q2 | $38M | Hold |
70,144
| – | – | 0.41% | 41 |
|
|
2024
Q1 | $36.4M | Hold |
70,144
| – | – | 0.41% | 41 |
|
|
2023
Q4 | $33.1M | Sell |
70,144
-656
| -0.9% | -$303K | 0.44% | 24 |
|
|
2023
Q3 | $30.8M | Hold |
70,800
| – | – | 0.42% | 26 |
|
|
2023
Q2 | $31.5M | Buy |
70,800
+538
| +0.8% | +$248K | 0.41% | 26 |
|
|
2023
Q1 | $32.3M | Hold |
70,262
| – | – | 0.44% | 24 |
|
|
2022
Q4 | $36M | Hold |
70,262
| – | – | 0.48% | 21 |
|
|
2022
Q3 | $31.9M | Sell |
70,262
-4,058
| -5% | -$1.94M | 0.44% | 19 |
|
|
2022
Q2 | $35.9M | Buy |
74,320
+3,320
| +5% | +$1.64M | 0.45% | 19 |
|
|
2022
Q1 | $34.9M | Sell |
71,000
-20,000
| -22% | -$9.14M | 0.38% | 21 |
|
|
2021
Q4 | $42.2M | Hold |
91,000
| – | – | 0.4% | 21 |
|
|
2021
Q3 | $33.9M | Sell |
91,000
-10,000
| -10% | -$3.8M | 0.35% | 22 |
|
|
2021
Q2 | $38.6M | Sell |
101,000
-20,000
| -17% | -$7.64M | 0.4% | 21 |
|
|
2021
Q1 | $43.4M | Hold |
121,000
| – | – | 0.43% | 22 |
|
|
2020
Q4 | $38.9M | Hold |
121,000
| – | – | 0.39% | 21 |
|
|
2020
Q3 | $32.5M | Sell |
121,000
-3,691
| -3% | -$993K | 0.37% | 24 |
|
|
2020
Q2 | $32.8M | Hold |
124,691
| – | – | 0.38% | 22 |
|
|
2020
Q1 | $28.3M | Buy |
124,691
+2,488
| +2% | +$678K | 0.39% | 23 |
|
|
2019
Q4 | $36.9M | Buy |
122,203
+1,123
| +0.9% | +$309K | 0.44% | 21 |
|
|
2019
Q3 | $29.1M | Hold |
121,080
| – | – | 0.37% | 23 |
|
|
2019
Q2 | $34.2M | Buy |
121,080
+112,985
| +1,396% | +$30.9M | 0.42% | 20 |
|
|
2019
Q1 | $2.32M | Buy |
8,095
+731
| +10% | +$211K | 0.03% | 88 |
|
|
2018
Q4 | $1.93M | Hold |
7,364
| – | – | 0.03% | 81 |
|
|
2018
Q3 | $2.02M | Hold |
7,364
| – | – | 0.03% | 93 |
|
|
2018
Q2 | $1.75M | Buy |
7,364
+2,364
| +47% | +$547K | 0.02% | 99 |
|
|
2018
Q1 | $1.1M | Hold |
5,000
| – | – | 0.02% | 101 |
|
|
2017
Q4 | $1.13M | Hold |
5,000
| – | – | 0.02% | 100 |
|
|
2017
Q3 | $950K | Buy |
+5,000
| New | +$952K | 0.01% | 106 |
|
Other funds holding ELV
C WorldWide Group's ELV Position: Q2 2026 in Review
C WorldWide Group held its Elevance Health (ELV) position steady in Q2 2026 at 65,000 shares worth $25.1M. The position accounts for 0.61% of the portfolio, ranked #27.
C WorldWide Group first reported a position in ELV in Q3 2017 and has held it in 36 quarters since. The position peaked at $43.4M in Q1 2021. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- C WorldWide Group held 65,000 shares of Elevance Health worth $25.1M as of Q2 2026.
- C WorldWide Group left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.61% of C WorldWide Group's portfolio in Q2 2026, its #27 holding.
- C WorldWide Group first reported a position in Elevance Health in Q3 2017 and has held it in 36 quarters since.
- C WorldWide Group's Elevance Health position peaked at $43.4M in Q1 2021.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.